 | Up a level |
Meliga, E; Garcia-Garcia, H M; Valgimigli, M; Chieffo, A; Biondi-Zoccai, G; Maree, A O; Gonzalo, N; Cook, S; Marra, S; Moretti, C; De Servi, S; Palacios, I F; Windecker, S; van Domburg, R; Colombo, A; Sheiban, I; Serruys, P W (2009). Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). International journal of cardiology, 137(1), pp. 16-21. Amsterdam: Elsevier 10.1016/j.ijcard.2008.06.006
Serruys, P; Morice, MC; Kappetein, P; Colombo, A; Holmes, DR; Mack, M; Carrel, TP (2009). Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. New England journal of medicine NEJM, 360(10), pp. 961-972. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0804626
Morice, MC; Colombo, A; Meier, B; Serruys, P; Tamburino, C; Guagliumi, G; Sousa, E; Stoll, HP; REALITY, Trial Investigators (2006). Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 295(8), pp. 895-904. New York, N.Y.: Elsevier 10.1001/jama.295.8.895
